Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
Status:
Completed
Trial end date:
2018-12-20
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of SADBE in the prevention of recurrent herpes
labialis in adults. Two-thirds of the participants will receive a SADBE solution, while the
other third will receive only the vehicle as a placebo control. The solutions will be
administered topically to the patient's arms. The study will compare a single-arm application
versus a two-arm application versus two placebo doses on the arm.